Therapeutic Asset Ratings

164 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Telisotuzumab Adizutecan Gastroesophageal Cancer	AbbVie	P1	CC (43)
Telisotuzumab Adizutecan Ovarian Serous Adenocarcinoma	AbbVie	P1	CC (43)
Abbv-1758 Alzheimer Disease	AbbVie	P1/2	CC (43)
Budigalimab Cancer	AbbVie	P1	CC (42)
Fosigotifator Amyotrophic Lateral Sclerosis	AbbVie	P1	CC (41)
Fosigotifator Major Depressive Disorder	AbbVie	P1	CC (41)
GILORALIMAB Triple-Negative Breast Carcinoma	AbbVie	P1	CC (41)
MAB HUMANIZED (IGG1) ANTI P43489 (TNR4_HUMAN) (ABBV368) Triple-Negative Breast Carcinoma	AbbVie	P1	CC (41)
Alia-1758 Alzheimer Disease	AbbVie	P1	CC (40)
gub014295 Obesity Disorder	AbbVie	P1	CC (40)
Abbv-291 Non-Hodgkin Lymphoma	AbbVie	P1	C (39)
Abbv-319 Diffuse Large B-Cell Lymphoma	AbbVie	P1	C (39)
Abbv-400 Esophageal Squamous Cell Carcinoma	AbbVie	P1	C (39)
Abbv-400 Gastroesophageal Adenocarcinoma	AbbVie	P1	C (39)
Abbv-525 Diffuse Large B-Cell Lymphoma	AbbVie	P1	C (39)
Abbv-525 Non-Hodgkin Lymphoma	AbbVie	P1	C (39)
Budigalimab Metastatic Malignant Neoplasm	AbbVie	P1	C (39)
GILORALIMAB Metastatic Malignant Neoplasm	AbbVie	P1	C (39)
Itraconazole Esophageal Squamous Cell Carcinoma	AbbVie	P1	C (39)
Levonorgestrel Hematopoietic And Lymphoid System Neoplasm	AbbVie	P1	C (39)
MAB HUMANIZED (IGG1) ANTI P43489 (TNR4_HUMAN) (ABBV368) Metastatic Malignant Neoplasm	AbbVie	P1	C (39)
ORSYTHIA COMPONENT ETHINYL ESTRADIOL Hematopoietic And Lymphoid System Neoplasm	AbbVie	P1	C (39)
TIPIRACIL Gastroesophageal Adenocarcinoma	AbbVie	P1	C (39)
Abbv-303 Neoplasm	AbbVie	P1	C (37)
Abbv-319 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	AbbVie	P1	C (37)

Showing 101 to 125 of 164 assets